FDA Publishes New Product-Specific Guidances to Facilitate Generic Drug DevelopmentOctober 1, 2025October 14, 2025
What Trump’s new Tariffs Mean for Pharmaceuticals and Patented DrugsSeptember 26, 2025September 29, 2025
FDA To Change Leucovorin Label to Reflect Potential Benefits in Treating AutismSeptember 22, 2025September 24, 2025
This Week: FDA Revokes LDT Rule, Monarez Warns About Vaccine Policies, Kennedy Called to Defend His DecisionsSeptember 19, 2025September 19, 2025
This Week at FDA: FDA’s Ad Crackdown, Abandoning AdComms, and MoreSeptember 12, 2025September 15, 2025
This Week at FDA: FDA to Scrutinize Co-Administered Vaccines, New CRLs, and a GLP-1 ‘Green List’September 5, 2025September 15, 2025
Kennedy Tries to Defend COVID-19 Vaccine Stance in Raucous Senate HearingSeptember 4, 2025September 4, 2025
